Gilead Expands Cancer Treatment Portfolio With New Acquisition

Gilead made plenty of headlines in 2020 with the development of Remdesivir, the COVID-19 drug that achieved an emergency use authorization and was available in hospitals beginning in July. The company has long been a leader in anti-viral therapies and is best known for their work with HIV and Hepatitis C...